Join us at the Westin Copley Place in Boston for the 50th Annual Psychopharmacology Conference, hosted by Massachusetts General Hospital and Harvard Medical School. This conference marks a meaningful milestone in the evolution of psychiatric education and care.
For five decades, this event has brought together leading experts and dedicated clinicians to advance the understanding and treatment of mental health conditions. In 2026, we reflect on that legacy—and look ahead to the next chapter.
This year’s program continues our commitment to clinical depth, scientific rigor, and practical application. Topics include:
Depression, Bipolar Disorder, and Anxiety
Psychosis and OCD
ADHD and PTSD
Substance Use Disorders
Integrative Approaches and Pharmacologic Innovations
Every session is designed to help you stay current on emerging research, examine evolving standards of care, and apply evidence-based strategies to complex clinical situations.
We offer Curbside Consultations—informal, scheduled opportunities to connect 1:1 with faculty members across a range of specialties. These conversations allow you to explore nuanced clinical questions or seek perspective on challenging cases (de-identified), all in a supportive and collegial format.
You can find the full schedule of Consultations in the agenda once made available.
MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before May 15, 2026): $830.00
Early Bird Registration (on or before August 15, 2026): $950.00
Regular Registration (after August 15, 2026): $1085.00
Other Professionals or Trainees
Super Early Bird Registration (on or before May 15, 2026): $675.00
Early Bird Registration (on or before August 15, 2026): $750.00
Regular Registration (after August 15, 2026): $850.00
THURSDAY TICKETED SESSIONS
DAYTIME:
Choose between the following TWO topics: Please note that you can only attend one of the daytime sessions.
Clozapine Workshop: $175
1:00-3:00 PM
Pharmacology 101 for Psychopharmacologists
1:00-3:00 PM
EVENING:
Choose between the following FIVE topics: Please note that you can only attend one of the evening sessions.
Thursday Evening Session: $200
4:00-8:00 PM - Dinner is included with the evening sessions.
We are also offering a full virtual option to accommodate those who can not attend in person.
For more information and to register, please click the link below.
NOTE: Thursday ticketed events and Friday and Saturday evening seminars are NOT included in the virtual registration option. These sessions will NOT be live-streamed.
Price: $95.00 (Please note, all syllabus purchases are non-refundable and non-shippable and must be picked up onsite at the conference)
The conference syllabus is a printed book with all slide presentations and space to take notes adjacent to each slide. As an alternative to purchasing a conference syllabus, we provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees.
We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference.
A refund minus a $100.00 administrative fee will be issued for refund requests received by October 1, 2026. No refunds will be issued for refund requests made after October 1, 2026. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.
Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.
Purchase a print copy of our Board Preparation book here!
As part of recertification requirements, physicians must participate in Maintenance of Certification Program (MOC) activities like this one to cultivate a focus on lifelong learning and competency throughout one’s profession. This module helps you hone in on clinical and practice management skills that are central to quality patient care and improved outcomes for patients.
This program is intended for psychiatrists, psychologists, general and family practice physicians, psychiatric nurses, physician assistants, nurse practitioners, and social workers.
By the end of this program, participants will be able to:
Identify rational, evidence-based pharmacologic and non-pharmacologic therapies for patients with unipolar, bipolar, treatment-resistant, and post-partum depression.
Compare the neurobiology and evidence-based treatment approaches to addiction, anxiety, schizophrenia, and mood disorders.
Review the course and treatment of psychiatric disorders during pregnancy and menopause.
Analyze drug interactions and the pharmacotherapy of adult ADHD and geriatric disorders.
Apply newer strategies in the treatment of chemical abuse/dependence.
Analyze evidence-based treatment for psychiatric illness.
Assess the most recent state-of-the-art treatment alternatives.
Assess new therapies and what is on the horizon.
Analyze the use of CBT-based techniques.
In support of improving patient care, MGH Institute of Health Professions is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Psychologists
Continuing Education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs. MGH Institute of Health Professions designates this activity for 32 CE credit.
Physicians
MGH Institute of Health Professions designates this live activity for a maximum of 32 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.
Physician Associates/Assistants
MGH Institute of Health Professions has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 32 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing
MGH Institute of Health Professions designates this activity for 32 contact hours for nurses. The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts credit from organizations accredited by the ACCME and ANCC.
Social Workers
As a Jointly Accredited Organization, the MGH Institute of Health Professions is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. State and provincial regulatory boards have the final authority to determine whether an individual course may be accepted for continuing education credit. MGH Institute of Health Professions maintains responsibility for this course. Social workers completing this course receive 32 clock hours for continuing education credits.
Pharmacist (ACPE)
This activity provides 32 contact hours (1.0 CEUs) of continuing education credit. ACPE Universal Activity Number UAN JA4008265-0000-24-000-L04-P
NOTE FOR PHARMACISTS: Upon closing of the electronic evaluation, MGH IHP will upload the pharmacy-related continuing education information to CPE Monitor within 60 days. Per ACPE rules, MGH IHP does not have access to or the ability to upload credits requested after the evaluation closes. It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP ePID and DOB (in MMDD format)] in order to receive credit for participating in a CE activity.
IPCE Credit
This activity was planned by and for the healthcare team, and learners will receive 32 Interprofessional Continuing Education (IPCE) credits for learning and change.
50th ANNUAL PSYCHOPHARMACOLOGY
OCTOBER 15-18, 2026
WESTIN COPLEY PLACE
BOSTON
THURSDAY, OCTOBER 15, 2026 – TICKETED EVENTS
1:00 – 3:00 PM Clozapine Workshop
Oliver Freudenreich, MD, FACLP
1:00 – 3:00 PM Pharmacology 101 for Psychopharmacologists
Frank Tazari, MBBS, PhD, MBA
4:00 – 8:00 PM The Role of Cannabis in Medicine
Eden Evins, MD, MPH; Jodi Gilman, PhD; Julia Arnsten, MD; Randi Schuster, PhD
4:00 – 8:00 PM Medical Issues in Psychiatry
Theodore A. Stern, MD; Christopher M. Celano, MD; Amy Newhouse, MD
4:00 – 8:00 PM Obesity and Eating Disorders
Kamryn Eddy, PhD; Laura Holsen, PhD; Ashley Dunford, PhD;
Esther Dechant, MD; Jennifer Thomas, PhD;
Evelyna Kambanis, PhD; Kendra Becker, PhD
4:00 – 8:00 PM Law & Psychiatry
Matthew Lahaie, MD, JD; Ronald Schouten, MD, JD;
Nikhil Mathews, MD, JD; Christine Darsney, PhD
4:00 – 8:00 PM Nutritional, Lifestyle, and Metabolic Psychiatry Program
Uma Naidoo, MD; David Mischoulon, MD;
Beth Frates, MD, FACLM, DipABLM; Ramaswamy Viswanathan, MD, DrMedSc;
Errol R. Norwitz, MD, PhD, MBA; Kimberley A. Parks, DO
FRIDAY, OCTOBER 16, 2026
8:00 – 8:10 AM Welcoming Remarks & Introduction
Maurizio Fava, MD & Jerrold F. Rosenbaum, MD
MODULE TOPIC – MOOD DISORDERS
8:10 – 8:55 AM Bipolar Depression
Andrew A. Nierenberg, MD
8:55 – 9:40 AM Bipolar Long-Term Management
Roy Perlis, MD
9:40 – 9:55 AM Break
9:55 – 10:40 AM Treatment Resistant Depression
Maurizio Fava, MD
10:40 – 11:20 AM Panel Discussion
Moderator: Jerrold F. Rosenbaum, MD
Panelists: Andrew A. Nierenberg, MD, Roy Perlis, MD, Maurizio Fava, MD
11:20 – 12:20 PM Lunch Break
MODULE TOPIC – ANXIETY/PTSD
12:20 – 1:05 PM PTSD & Insomnia
Amit Chopra, MBBS, DFAPA
1:05 – 1:50 PM Anxiety Disorders and Treatments
Jerrold F. Rosenbaum, MD
1:50 – 2:30 PM Panel Discussion
Moderator: Lee Cohen, MD
Panelists: Amit Chopra, MBBS, DFAPA, Jonah Cohen, PhD, Jerrold F. Rosenbaum, MD
2:30 – 2:45 PM Break
MODULE TOPIC – WOMEN’S HEALTH
Lee S. Cohen, MD
3:30 – 4:15 PM Postpartum Mood and Anxiety Disorders
Marlene P. Freeman, MD
4:15 – 4:55 PM Panel Discussion
Moderator: Lee S. Cohen, MD
Panelist: Marlene P. Freeman, MD, Laura Fagioli Petrillo, EdM, MD
4:55 – 5:15 PM Break
5:15 – 7:15 PM Friday Evening Seminars:
Seminars begin at 5:15 PM and repeat at 6:15 PM.
Pharmacologic Approach to Psychiatric Urgent Care
Meaghan Rudolph, MS, RN, PMHCNS-BC
Psychopharmacology of Sleep Disorders
John Winkelman, MD, PhD
Prodromes, Early Detection and Prevention of Major Psychiatric Illnesses
Daphne Holt, MD, PhD
Mental Health and the Benefits of a Healthy Lifestyle
Maren Nyer, PhD
Stimulation and/or Surgical Approaches to Psychiatric Illness
Cristina Cusin, MD
PMDD and Depression During the Menopausal Transition: New Insights
Laura Fagioli Petrillo, EdM, MD
Suicide
Theodore A. Stern, MD
7:15 PM Adjourn
SATURDAY, OCTOBER 17, 2026
8:00 – 8:05 AM Welcoming Remarks & Introduction
Oliver Freudenreich, MD, FACLP
MODULE TOPIC – PSYCHOSIS
8:05 – 8:50 AM First-Episode Psychosis and Schizophrenia
Oliver Freudenreich, MD, FACLP
8:50 – 9:35 AM Management of Side-Effects of Antipsychotics
Abigail Donovan, MD
9:35 – 9:50 AM Break
MODULE TOPIC – KETAMINE & ESKETAMINE
9:50 – 10:35 AM Ketamine and Esketamine: From Research to Clinical Practice
Cristina Cusin, MD
10:35 – 11:15 AM Panel Discussion
Moderator: David Mischoulon, MD
Panelists: Cristina Cusin, MD, Oliver Freudenreich, MD, FACLP, Abigail Donovan, MD
11:15 – 12:15 PM Lunch Break
MODULE TOPIC – NEW THERAPIES: WHAT IS ON THE HORIZON?
12:15 – 1:00 PM Neuromodulation and Interventional Psychiatry
Joan Camprodon, MD, MPH
1:00 – 1:45 PM New Treatments for Schizophrenia
Oliver Freudenreich, MD, FACLP
1:45 – 2:00 PM Break
2:00 – 2:45 PM Psychedelics
Franklin King, MD
John F. Kelly, PhD
3:30 – 4:20 PM Panel Discussion
Moderator: Oliver Freudenreich, MD, FACLP
Panelists: Franklin King, MD, Joan Camprodon, MD, MPH, John F. Kelly, PhD
4:20 – 4:30 PM Break
4:30 – 5:30 PM Saturday Evening Seminars:
Seminars begin at 4:30 PM and do not repeat.
James Barrett, PhD; Superintendent Frederick Cabral
Jennifer R. Gatchel, MD, PhD
Kaloyan S. Tanev, MD
Jodi Gilman, PhD
Gagan Joshi, MD
Chris McDougle, MD
David Mischoulon, MD, PhD
5:30 PM Adjourn
SUNDAY, OCTOBER 18, 2026
7:55- 8:00 AM Welcoming Remarks & Introduction
David Rubin, MD
MODULE TOPIC – ADDICTION
8:00 – 8:40 AM Alcohol and Opioids
Vinod Rao, MD, PhD
8:40 – 9:20 AM Treatment of Tobacco Use Disorders
Anne Eden Evins, MD
9:20 – 9:50 AM Panel Discussion
Moderator: David Rubin, MD
Panelists: Vinod Rao, MD, PhD, Anne Eden Evins, MD
9:50 – 10:05 AM Break
MODULE TOPIC – OCD
10:05 – 10:50 AM Psychopharmacology of OCD
Lisa M. Zakhary, MD, PhD
10:50 – 11:35 AM Psychopharmacology for Obsessive-Compulsive Related Disorders
Erica Greenberg, MD
Sabine Wilhelm, PhD
12:20 – 12:50 PM Panel Discussion
Moderator: Sabine Wilhelm, PhD
Panelists: Lisa M. Zakhary, MD, PhD, Erica Greenberg, MD
12:50 – 1:50 PM Lunch Break
MODULE TOPIC – ACROSS THE LIFESPAN
1:50 – 2:35 PM Pediatric Bipolar Disorder and Mood Disorders
Mai Uchida, MD
2:35 – 3:20 PM ADHD
Timothy Wilens, MD
3:20 – 4:05 PM Drug Interactions
Jonathan E. Alpert, MD, PhD
4:05 – 4:45 PM Panel Discussion
Moderator: Timothy Wilens, MD
Panelists: Jonathan E. Alpert, MD, Mai Uchida, MD
4:45 PM Adjourn
Policy on Faculty and Provider Disclosure:
Disclosure Information
In accordance with the disclosure policy of MGH Institute of Health Professions as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all financial relationships with ineligible companies for the past 24 months, as defined below:
Ineligible Companies
The ACCME defines an “Ineligible company” as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” For more information, visit accme.org/standards.
Financial Relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Mitigation of Financial Relationships
All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.
Maurizio Fava, MD
Chair, Mass General Brigham Academic Medical Centers (AMC) Department of Psychiatry
Co-Chair, Mass General Brigham Research Oversight Committee (ROC)
Executive Director, Clinical Trials Network and Institute (CTNI)
Mass General Brigham (MGB)
Slater Family Professor of Psychiatry
Harvard Medical School
Jerrold F. Rosenbaum, MD
Psychiatrist-in-Chief Emeritus
Director, Center for the Neuroscience of Psychedelics
Massachusetts General Hospital
Stanley Cobb, Professor of Psychiatry, Harvard Medical School
Jonathan E. Alpert, MD, PhD
Silverman University Chair, Department of Psychiatry and Behavioral Sciences
Professor of Psychiatry, Neuroscience, and Pediatrics
Psychiatrist-in-Chief
Montefiore Medical Center
Albert Einstein College of Medicine
James Barrett, PhD
Director of Clinical Support, Cambridge Police
Assistant Professor of Psychology (part-time)
Harvard Medical School
Khadijah Booth Watkins, MD, MPH, DFAACAP
Interim Director, Child and Adolescent Psychiatry Residency Training
Associate Director, The Clay Center for Young Healthy Minds
Associate Director, Psychiatry Clerkship, Harvard Medical School
Instructor, Harvard Medical School
Frederick Cabral
Superintendent Support Services
Cambridge Police
Joan Camprodon, MD, MPH, PhD
Chief, Division of Neuropsychiatry
Director, Laboratory for Neuropsychiatry & Neuromodulation
Director, Transcranial Magnetic Stimulation (TMS) clinical service
Massachusetts General Hospital
Associate Professor of Psychiatry, Harvard Medical School
Amit Chopra, MBBS, DFAPA
Psychiatrist and Sleep Specialist
Massachusetts General Hospital
Assistant Professor, Harvard Medical School
Jonah Cohen, PhD
Associate Director, Center for Anxiety
and Traumatic Stress Disorders
Lee S. Cohen, MD
Director, Ammon-Pinizzotto Center for Women’s Mental Health
Perinatal and Reproductive Psychiatry Clinical Research Program
Massachusetts General Hospital
Associate Chief of Psychiatry (Philanthropy and Department Communications)
Edmund and Carroll Carpenter Professor of Psychiatry
Harvard Medical School
Cristina Cusin, MD
Director, Ketamine Clinic and Associate Director, Depression Clinical and Research Program
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School
Abigail L. Donovan, MD
Medical Director, Acute Psychiatry Service
Director of Clinical Services, Psychosis Clinical and Research Program
Director, First Episode and Early Psychosis Program
Massachusetts General Hospital
A. Eden Evins, MD, MPH
Cox Family Professor of Psychiatry, Harvard Medical School
Founding Director, Mass General Hospital Center for Addiction Medicine
Director for Faculty Development, Mass General Hospital Department of Psychiatry
Laura Fagioli Petrillo, EdM, MD
Director of Training
The Ammon-Pinizzotto Center for Women’s Mental Health, Massachusetts General Hospital
Instructor in Psychiatry, Harvard Medical School
Maurizio Fava, MD
Chair, Mass General Brigham Academic Medical Centers (AMC) Department of Psychiatry
Co-Chair, Mass General Brigham Research Oversight Committee (ROC)
Executive Director, Clinical Trials Network and Institute (CTNI)
Mass General Brigham (MGB)
Slater Family Professor of Psychiatry
Harvard Medical School
Marlene P. Freeman, MD
Professor of Psychiatry, Harvard Medical School
Massachusetts General Hospital Department of Psychiatry
Director of Clinical Services and Associate Director,
Ammon-Pinizzotto Center for Women’s Mental Health, Perinatal and Reproductive Psychiatry
Abra Prentice Foundation Chair in Women’s Mental Health
Medical Director, MGH Clinical Trials Network and Institute
Editor in Chief, The Journal of Clinical Psychiatry
Oliver Freudenreich, MD, FACLP
Professor of Clinical Psychiatry
Harvard Medical School
Co-Director, MGH Psychosis Clinical and Research Program
Massachusetts General Hospital
Jennifer R. Gatchel, MD, PhD
Assistant Psychiatrist, Massachusetts General Hospital/McLean Hospital
Partners Geriatric Psychiatry Fellowship, MGH Site Director
Assistant Professor of Psychiatry, Harvard Medical School
Jodi M. Gilman, PhD
Director of Neuroscience, MGH Center for Addiction Medicine
Director, MGH Graduate Student and Postdoctoral Division
Associate Professor, Harvard Medical School
Department of Psychiatry
Erica Greenberg, MD
Director, Pediatric Psychiatry OCD and Tic Disorders Program
MassGeneral Brigham, Massachusetts General Hospital
Assistant Professor of Psychiatry, Harvard Medical School
Daphne Holt, MD, PhD
Director, Resilience and Prevention Program, MGH Department of Psychiatry
Co-Director, Psychosis Research and Clinical Program, MGH Department of Psychiatry
Associate Professor, Harvard Medical School
Gagan Joshi, MD
Director, The Alan & Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorder
David and Joanne Rovee Chair in Child Psychiatry
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School
John F. Kelly, PhD, ABPP
Chief, Division of Addiction Treatment and Prevention, Mass General Brigham AMC, Dept of Psychiatry
Elizabeth R. Spallin, Professor of Psychiatry, Harvard Medical School
Founder and Director, MGH Recovery Research Institute
Founder and Director, National Center on Youth Prevention, Treatment, and Recovery
President, American Board of Addiction Psychology
Board Certified Addiction Psychologist
Franklin King IV, MD
Franklin King, MD
Director of Training and Education, MGH Center for Neuroscience of Psychedelics
Instructor, Harvard Medical School
Christopher J. McDougle, MD
Director, Lurie Center for Autism
Massachusetts General Hospital
Nancy Lurie Marks Professor of Psychiatry
Harvard Medical School
David Mischoulon, MD, PhD
Director, Depression Clinical and Research Program
Mass General Brigham Academic Medical Center's Psychiatry Department
Joyce R Tedlow, Professor of Psychiatry, Harvard Medical School
Andrew A. Nierenberg, MD
Thomas P. Hackett, MD, Endowed Chair in Psychiatry at MGH
Director, Dauten Family Center for Bipolar Treatment Innovation
Co-Director, Center for Clinical Research Education, Division of Clinical Research
Massachusetts General Hospital
Professor of Psychiatry, Harvard Medical School
Maren Nyer, PhD
Clinical Psychologist & Director of Yoga Research, Massachusetts General Hospital
Depression Clinical and Research Program (DCRP); Assistant Professor
Harvard Medical School
Roy H. Perlis, MD, MSc
Associate Chief (Research), Department of Psychiatry
Director, Center for Quantitative Health
Ronald I. Dozoretz, MD Endowed Chair
Massachusetts General Hospital
Professor of Psychiatry
Harvard Medical School
Affiliate Faculty
Center for Genomic Medicine, Harvard Stem Cell Institute
Broad Institute of MIT and Harvard
Vinod Rao, MD, PhD
Medical Director, MGH West End Clinic
Chief, MGB Psychiatry Division of Adult Outpatient Psychiatry
Jerrold F. Rosenbaum, MD
Psychiatrist-in-Chief Emeritus
Director, Center for the Neuroscience of Psychedelics
Massachusetts General Hospital
Stanley Cobb, Professor of Psychiatry, Harvard Medical School
David H. Rubin, MD
Director, Division of Professional and Public Education, MGH
Executive Director, MGH Psychiatry Academy and MGH Visiting, MGH
Assistant Professor, Harvard Medical School
Meaghan Rudolph, MS, RN, PMHCNS-BC
Psychiatric Clinical Nurse Specialist, MGH Department of Psychiatry
Instructor, MGH Institute of Health Professions
Theodore A. Stern, MD
Chief Emeritus, Avery D. Weisman Psychiatric Consultation Service,
Director, Thomas P. Hackett Center for Scholarship in Psychosomatic Medicine
Massachusetts General Hospital;
Ned H. Cassem, Professor of Psychiatry in the field of
Psychosomatic Medicine/Consultation,
Harvard Medical School
Editor-in-Chief Emeritus, Psychosomatics/JACLP
Kaloyan Tanev, MD, MPH
Chief Medical Officer, The Home Base Program
Chief Scientific Officer, The Home Base Program
Inaugural Thomas C. Werner Endowed Chair for Military Health
Medical Director, MGH TBI Clinical and Research Program
Director of Clinical Neuropsychiatry Research, MGH
Associate Professor in Psychiatry, Harvard Medical School
Mai Uchida, MD
Associate Professor, Department of Psychiatry, Harvard Medical School
Director of Pediatric Depression/ Director of Global Advocacy
Division of Child and Adolescent Psychiatry
Massachusetts General Hospital
Timothy E. Wilens, MD
Chief, Division of Child and Adolescent Psychiatry,
Massachusetts General Hospital/Brigham and Women's Hospital
Professor of Psychiatry,
Harvard Medical School
President-Elect, American Academy of Child and Adolescent Psychiatry
Sabine Wilhelm, PhD
Chief of Psychology, Mass General Brigham (MGB), Psychiatry Department
Director, Center for Digital Mental Health, Massachusetts General Hospital (MGH)
Director, Center for OCD and Related Disorders, MGH
Donovan-Chien Family Endowed Professor in Psychology at Harvard Medical School
John W. Winkelman, MD, PhD
Chief, Sleep Disorders Clinical Research Program
Departments of Psychiatry and Neurology
Massachusetts General Hospital Professor of Psychiatry
Harvard Medical School
Lisa M. Zakhary, MD, PhD
Medical Director, Center for OCD and Related Disorders
Medical Director, Primary Care Psychiatry
Director of Psychopharmacology, Excoriation Clinic and Research Unit
Massachusetts General Hospital
Assistant Professor, Harvard Medical School
MGH Institute of Health Professions has been authorized by the American Academy of PAs (AAPA) to award 32.00 credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 32.00 AAPA Category 1 CME credits. Approval is valid until then end of this course. PAs should only claim credit commensurate with the extent of their participation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this live activity for a maximum of 32.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 32.00 contact hours of nursing continuing education credit.
Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 32.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR.
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists.
The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content. This offering meets the criteria for 32.00 Continuing Education (CE) credits per presentation for psychologists.
We have a dedicated staff member who is available by phone 5 days per week between 8 am and 5 pm by calling 866-644-7792 or email at mghcme@mgh.harvard.edu. All inquiries will be dealt with in a timely (within one business day) and professional manner. Requests for credits or refunds will be reviewed by the Director of the Division of Professional and Public Education, Massachusetts General Hospital. Please refer to our cancellation policy for additional information.”